{"id":"W2917537905","doi":"10.1200/jco.18.00605","title":"First-Line Treatment of Patients With Indolent Non-Hodgkin Lymphoma or Mantle-Cell Lymphoma With Bendamustine Plus Rituximab Versus R-CHOP or R-CVP: Results of the BRIGHT 5-Year Follow-Up Study","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":307,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Ottawa Hospital","funders":"","keywords":"Medicine; Rituximab; Vincristine; Bendamustine; Mantle cell lymphoma; CHOP; Internal medicine; Hazard ratio; Prednisone; Cyclophosphamide; Oncology; Gastroenterology; Lymphoma; Surgery; Chemotherapy; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004881705,0.0005004716,0.002041872,0.0003631915,0.000296847,0.0009692906,0.0006015922,0.0008804036,0.001348263],"category_scores_gemma":[0.002593864,0.0002870962,0.002209488,0.0002575618,0.0003766908,0.0008219238,0.0003506877,0.001782867,0.0002729087],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001017047,"about_ca_system_score_gemma":0.0006910889,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005943986,"about_ca_topic_score_gemma":0.001743629,"domain_scores_codex":[0.9985498,0.0008595374,0.00007802259,0.0001572744,0.000170139,0.000185308],"domain_scores_gemma":[0.9977975,0.000612814,0.0007079844,0.0001630517,0.0001255559,0.0005931081],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.770853,0.01513859,0.05511371,0.001356618,0.009914717,0.0001387977,0.0001719058,0.001219405,0.005741143,0.0001648349,0.002651015,0.1375363],"study_design_scores_gemma":[0.2457438,0.475002,0.2602169,0.0003306626,0.009595286,0.0004374849,0.0001384797,0.001845252,0.002210806,0.0003760464,0.004023888,0.00007941565],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9808459,0.01642814,0.0002807254,0.0003330059,0.0001269481,0.0002755996,0.000590631,0.00002970481,0.001089398],"genre_scores_gemma":[0.9945089,0.002344544,0.0003073316,0.0007048374,0.0001829689,0.0001421525,0.001048237,0.000006185297,0.000754844],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004881705,"threshold_uncertainty_score":0.02581728,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06547427927673023,"score_gpt":0.3718566737576587,"score_spread":0.3063823944809285,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}